Advanced in Optic Atrophy Type 1

Dr. Nancy J. Newman

Ophthalmology | Neurology
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Advanced in Optic Atrophy Type 1
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nancy Newman is an Ophthalmologist and a Neurologist in Atlanta, Georgia. Dr. Newman is rated as an Advanced provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, Pseudotumor Cerebri Syndrome, Increased Intracranial Pressure, and Embolectomy. Dr. Newman is currently accepting new patients.

Her clinical research consists of co-authoring 240 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Neurology
Licenses
Ophthalmology in GA
Hospital Affiliations
Grady Memorial Hospital
Emory University Hospital
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

EMORY MEDICAL CARE FOUNDATION INC
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303
Other Locations
THE EMORY CLINIC INC
1365 Clifton Rd Ne, Atlanta, GA 30322

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Genetic, Other
Study Phase: Phase 3
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Biological, Device
Study Phase: Phase 3
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Enrollment Status: Completed
Publish Date: February 08, 2021
Intervention Type: Other
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Biological, Device
Study Phase: Phase 3
View 6 Less Clinical Trials

240 Total Publications

The Emory Optic Nerve Head Atlas - Using 3D Anatomical Mapping to Study Optic Neuropathies with an Initial Focus on Glaucoma.
The Emory Optic Nerve Head Atlas - Using 3D Anatomical Mapping to Study Optic Neuropathies with an Initial Focus on Glaucoma.
Journal: ArXiv
Published: December 03, 2025
Similar Doctors
Gayle L. Goldstein
Distinguished in Optic Atrophy Type 1
Dr. Gayle L. Goldstein
Ophthalmology
Distinguished in Optic Atrophy Type 1
Dr. Gayle L. Goldstein
Ophthalmology

Georgia Eye Partners

1700 Tree Lane, Suite 135, 
Snellville, GA 
 (22.4 miles away)
770-736-7020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gayle Goldstein is an Ophthalmologist in Snellville, Georgia. Dr. Goldstein is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. Her top areas of expertise are Blepharitis, Cataract, Glaucoma, and Optic Nerve Atrophy. Dr. Goldstein is currently accepting new patients.

Advanced in Optic Atrophy Type 1
Dr. Jing Dong
Ophthalmology
Advanced in Optic Atrophy Type 1
Dr. Jing Dong
Ophthalmology

Jing Dong MD PC

651 S Milledge Ave, 
Athens, GA 
 (58.7 miles away)
706-546-9290
Languages Spoken:
English, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Jing Dong is an Ophthalmologist in Athens, Georgia. Dr. Dong is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Cataract, Glaucoma, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Deep Brain Stimulation. Dr. Dong is currently accepting new patients.

Advanced in Optic Atrophy Type 1
Dr. Arkadiy B. Yadgarov
Ophthalmology
Advanced in Optic Atrophy Type 1
Dr. Arkadiy B. Yadgarov
Ophthalmology

Southeast Eye Surgery Center Pc.

5505 Peachtree Dunwoody Rd, Suite 300, 
Atlanta, GA 
 (10.6 miles away)
404-257-0814
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients

Arkadiy Yadgarov is an Ophthalmologist in Atlanta, Georgia. Dr. Yadgarov is rated as a Distinguished provider by MediFind in the treatment of Optic Atrophy Type 1. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal. Dr. Yadgarov is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Newman's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile